Those come on top of compensation already paid by Servier to victims ... which was approved for diabetes but widely used as an appetite suppressant. It was eventually withdrawn from sale in ...

Servier’s decision to exit a Parkinson’s disease pact has triggered belt tightening at French biotech Oncodesign Precision Medicine. The loss of a shot at a milestone prompted OPM to lay off ...

Servier is focused on innovation in cardiovascular, immune-inflammatory and neuropsychiatric diseases, cancer and diabetes, as well as generic drugs. It also offers eHealth solutions beyond drug ...